An increased risk of both invasive and superficial fungal infections was observed among patients who received TNF-α inhibitors for various conditions.

The Invasive Fungal Infection (IFI) market is witnessing a transformative shift driven by innovative solutions aimed at combating these pervasive threats to human health. With a growing incidence of ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...

Background: Invasive candidiasis is increasingly prevalent in premature infants and seriously ill children, and pediatric data on available antifungal therapies are lacking. Methods: We conducted ...

Andrej Spec, MD, leads the Invasive Fungal Infections Clinic at WashU Medicine, a globally recognized center that treats ...

Fungal infections in India are rising, with growing resistance to treatment. Learn about common types, causes, drug ...

Caspofungin was approved for use in Costa Rica in October 2001 (Cancidas; Merck Sharp and Dohme) for patients older than 16 years, with invasive Candida spp. or Aspergillus spp. that fail to ...

Candida auris is a species of fungus that can cause healthcare-associated invasive infections and outbreaks, posing a serious threat to global human health, according to Health Canada’s webpage ...

Desai, L. Kovanda - Poster P2946: Deciphering Connections Between Isavuconazole Drug Exposures and Responses Among Different Infections: Invasive Candidiasis – L. Kovanda, A. Desai - Poster ...